Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

CalAmp (CAMP) Stock Forecast & Price Target

CalAmp logo
Get the Latest News and Ratings for CAMP and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for CalAmp and its competitors.

Sign Up

CAMP Analyst Ratings Over Time

TypeCurrent Forecast
11/24/23 to 11/23/24
1 Month Ago
10/25/23 to 10/24/24
3 Months Ago
8/26/23 to 8/25/24
1 Year Ago
11/24/22 to 11/24/23
Strong Buy
1 Strong Buy rating(s)
N/A
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
N/A
1 Buy rating(s)
1 Buy rating(s)
Hold
0 Hold rating(s)
N/A
1 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
N/A
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$19.33N/A$63.25$63.25
Forecasted Upside257.36% UpsideN/A15,712.50% Upside643.24% Upside
Consensus Rating
Buy
N/A
Moderate Buy
Hold

CAMP Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CAMP Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

CalAmp Stock vs. The Competition

TypeCalAmpMedical CompaniesS&P 500
Consensus Rating Score
3.20
2.80
2.50
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside257.36% Upside26,878.84% Upside7.66% Upside
News Sentiment Rating
Neutral News

See Recent CAMP News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/5/2024Leerink Partnrs
5 of 5 stars
M. Foroohar
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
11/5/2024Leerink Partners
1 of 5 stars
 Initiated CoverageOutperform$17.00+106.81%
11/5/2024William Blair
2 of 5 stars
M. Minter
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform
11/5/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
E. Tenthoff
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$18.00+118.98%
11/5/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight$23.00+179.81%
10/6/2023Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$138.00 ➝ $115.00+1,332.66%
10/6/2023Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$11.50+10.62%
6/26/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 04:42 AM ET.


CAMP Forecast - Frequently Asked Questions

According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for CalAmp is $19.33, with a high forecast of $23.00 and a low forecast of $17.00.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CalAmp in the last twelve months. There are currently 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CAMP shares.

According to analysts, CalAmp's stock has a predicted upside of 257.36% based on their 12-month stock forecasts.

Over the previous 90 days, CalAmp's stock had 1 upgrade by analysts.

CalAmp has been rated by research analysts at JPMorgan Chase & Co., Leerink Partners, Leerink Partnrs, Piper Sandler, and William Blair in the past 90 days.

Analysts like CalAmp more than other "medical" companies. The consensus rating for CalAmp is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CAMP compares to other companies.


This page (NASDAQ:CAMP) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners